<?xml version="1.0"?>
<law>
  <structure>
    <unit label="article" identifier="gec" order_by="" level="1">Economic Development</unit>
  </structure>
  <section_number>gec-10-448</section_number>
  <catch_line>...</catch_line>
  <order_by>448</order_by>
  <text>
    <section prefix="(a)">There is a Coordinating Emerging Nanobiotechnology Research in Maryland Fund in the Corporation.</section>
    <section prefix="(b)">
      <section prefix="(1)">The Fund is a special, nonlapsing fund that is not subject to reversion under &#xA7; 7-302 of the State Finance and Procurement Article.</section>
      <section prefix="(2)">The Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.</section>
    </section>
    <section prefix="(c)">The Fund consists of:<section prefix="(1)">appropriations as provided in the State budget; and</section><section prefix="(2)">any other money from any other source accepted for the benefit of the CENTR Maryland Program.</section></section>
    <section prefix="(d)">The Executive Director of the Corporation, or the Executive Director's designee, shall administer the Fund in accordance with this part and other applicable law.</section>
    <section prefix="(e)">The Fund shall be used to cover the costs of the Program, including any grants that are awarded to eligible recipients.</section>
    <section prefix="(f)">
      <section prefix="(1)">The Treasurer shall invest the money of the Fund in the same manner as other State money may be invested.</section>
      <section prefix="(2)">Any investment earnings of the Fund shall be credited to the Fund.</section>
    </section>
    <section prefix="(g)">The Legislative Auditor shall audit the accounts and transactions of the Fund as provided in &#xA7; 2-1220 of the State Government Article.</section>
  </text>
</law>
